Back to CVE records
High 7.6Published Oct 3, 2025

CVE-2025-52653Cross Site Scripting vulnerability in the web application

Updated under an hour ago ()

This data is behind schedule: last updated Oct 26, 2026, 11:50 PM ET. We are working on it.Behind: CVE records (cvelistV5).

Does this affect you?

It affects HCL MyXalytics and 1 other product. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.

CVSS
7.6 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:L/A:H
Weakness (CWE)
CWE-79
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
HCL
NVD analysis
Analyzed
Record last updated
Oct 3, 2025
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
HCL HCL MyXalytics
hcl:myxalytics (from the name)
6.6
CNA record
hcltech dryice_myxalytics
hcltech:dryice_myxalytics
6.6
NVD

References

References

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.